Dimensional Fund Advisors
PRVL

Dimensional Fund Advisors’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Dimensional Fund Advisors’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-21,020
Closed -$485K – 3448
2020
Q4 		$485K Sell
21,020
-548
-3% -$6.95K ﹤0.01% 3095
2020
Q3 		$219K Buy
+21,568
New +$289K ﹤0.01% 3194

Dimensional Fund Advisors's PRVL Position: Q1 2021 in Review

Dimensional Fund Advisors sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 21,020 shares — an estimated $485K sold.

Dimensional Fund Advisors first reported a position in PRVL in Q3 2020 and held it in 2 quarters. The position peaked at $485K in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

  • Dimensional Fund Advisors reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Dimensional Fund Advisors sold 21,020 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $485K.
  • Dimensional Fund Advisors first reported a position in Prevail Therapeutics Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Dimensional Fund Advisors's Prevail Therapeutics Inc. Common Stock position peaked at $485K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on Dimensional Fund Advisors's 13F filing for Q1 2021, filed 14 May 2021.